Skip to main content
. 2022 Mar 15;12:824511. doi: 10.3389/fonc.2022.824511

Figure 6.

Figure 6

Disproportionality analysis of ICI-induced neurologic irADRs belonging to (A) the “Peripheral neuropathies”, (B) the “Headaches”, (C) the “Neuromuscular disorders”, (D) “Neurological disorders NEC”, and (E) “Central nervous system vascular disorders” HLGTs comparing the different ICI classes to each other (anti-PD-1 vs. anti-PD-L1 vs. anti-CTLA-4).